Tunstead, Courteney and Volkova, Evelina and Dunbar, Hazel and Hawthorne, Ian J. and Bell, Alison and Crowe, Louise and Masterson, Joanne C. and Dos Santos, Claudia C. and McNicholas, Bairbre and Laffey, John G. and English, Karen
(2024)
The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation.
Molecular Therapy, 32 (10).
pp. 3422-3432.
ISSN 1525-0016
Abstract
Clinical trials investigating the potential of mesenchymal stromal cells (MSCs) for the treatment of inflammatory diseases,
such as acute respiratory distress syndrome (ARDS), have
been disappointing, with less than 50% of patients responding
to treatment. Licensed MSCs show enhanced therapeutic efficacy in response to cytokine-mediated activation signals. There
are two distinct sub-phenotypes of ARDS: hypo- and hyper-inflammatory. We hypothesized that pre-licensing MSCs in a hyper-inflammatory ARDS environment would enhance their
therapeutic efficacy in acute lung inflammation (ALI). Serum
samples from patients with ARDS were segregated into hypoand hyper-inflammatory categories based on interleukin
(IL)-6 levels. MSCs were licensed with pooled serum from patients with hypo- or hyper-inflammatory ARDS or healthy
serum controls. Our findings show that hyper-inflammatory
ARDS pre-licensed MSC conditioned medium (MSCCMHyper) led to a significant enrichment in tight junction
expression and enhanced barrier integrity in lung epithelial
cells in vitro and in vivo in a vascular endothelial growth
factor (VEGF)-dependent manner. Importantly, while both
MSC-CMHypo and MSC-CMHyper significantly reduced IL-6
and tumor necrosis factor alpha (TNF-a) levels in the
bronchoalveolar lavage fluid (BALF) of lipopolysaccharide
(LPS)-induced ALI mice, only MSC-CMHyper significantly
reduced lung permeability and overall clinical outcomes
including weight loss and clinical score. Thus, the hypo- and
hyper-inflammatory ARDS environments may differentially
influence MSC cytoprotective and immunomodulatory functions.
Item Type: |
Article
|
Keywords: |
MSC; ARDS SARS-CoV-2; VEGF; permeability; |
Academic Unit: |
Faculty of Science and Engineering > Biology |
Item ID: |
19173 |
Identification Number: |
https://doi.org/10.1016/j.ymthe.2024.08.003 |
Depositing User: |
Karen English
|
Date Deposited: |
11 Nov 2024 16:59 |
Journal or Publication Title: |
Molecular Therapy |
Publisher: |
Elsevier |
Refereed: |
Yes |
URI: |
|
Use Licence: |
This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available
here |
Repository Staff Only(login required)
|
Item control page |
Downloads per month over past year
Origin of downloads